Moderna Inc. (MRNA)
NASDAQ: MRNA
· Real-Time Price · USD
23.45
-1.94 (-7.64%)
At close: Sep 12, 2025, 12:26 PM
-7.64% (1D)
| Bid | 23.47 |
| Market Cap | 9.12B |
| Revenue (ttm) | 3.06B |
| Net Income (ttm) | -2.9B |
| EPS (ttm) | -7.51 |
| PE Ratio (ttm) | -3.12 |
| Forward PE | -3.24 |
| Analyst | Hold |
| Ask | 23.49 |
| Volume | 797,803 |
| Avg. Volume (20D) | 10,750,787.1 |
| Open | 25.23 |
| Previous Close | 25.39 |
| Day's Range | 23.18 - 25.41 |
| 52-Week Range | 23.15 - 75.37 |
| Beta | 1.93 |
About MRNA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MRNA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MRNA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Moderna Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
41 minutes ago
Vaccine stocks are trading lower after a report in...
Unlock content with
Pro Subscription
2 weeks ago
-6.53%
Shares of vaccine companies are trading lower following a Daily Beast report suggesting that President Trump and Health and Human Services Robert F. Kennedy, Jr. will ban Covid-19 vaccines "within months." Also, a report suggested that a Covid-19 vaccine skeptic will lead the Covid-19 immunization task force.
1 week ago · seekingalpha.com
What Moved Markets This WeekListen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
